ArticleBMC oral health2026
Combination of Lacticaseibacillus rhamnosus and Weissella confusa treatment improves ligature-induced periodontitis in rats via immune modulation and inhibition of oral pathogens.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundPeriodontitis is a chronic inflammatory disease driven by bacterial biofilms and host immune responses. Conventional treatments, such as mechanical debridement and antibiotics, have inherent limitations. These include antibiotic resistance and incomplete pathogen elimination. Consequently, there is a growing need for novel therapeutic strategies. Probiotics represent a promising adjunct therapy due to their potential to modulate the oral microbiota and host immunity.
methodsProbiotic bacteria were isolated from infant fecal samples, and Guiyang fermented cabbage using spread plating on Man, Rogosa, and Sharpe (MRS) agar. Following isolation, candidate strains were screened in vitro for anti-inflammatory activity using an inflammatory cell model, assessing the levels of IL-1β, IL-6, and TNF-α. Subsequently, a ligature-induced rat periodontal disease model was used to evaluate the in vivo therapeutic efficacy. Clinical periodontal parameters, including probing depth and gingival bleeding, were systematically evaluated, along with assessment of inflammatory markers.
resultsIn vitro screening of the anti-inflammatory capacity of six isolated probiotic strains and their combinations revealed that Lacticaseibacillus rhamnosus LHJY (LGG), Weissella confusa LHJY (W. c), and the LGG + W. c combination exhibited superior anti-inflammatory activity compared to other strains. In vitro experiments demonstrated that the probiotic combination effectively inhibited the growth of key periodontal pathogens. Furthermore, the combination exhibited potential for modulating inflammatory responses. In a ligature-induced rat periodontitis model, the combined probiotic treatment significantly improved clinical parameters, including probing depth and gingival bleeding, compared to single-strain treatments, while concurrently suppressing host inflammatory responses. These results suggest that the combined intervention of LGG and W. c, exerts a significant effect in regulating local immunity, inhibiting pathogenic bacteria, and alleviating periodontal tissue destruction.
conclusionsThis study provides novel experimental evidence for the efficacy of a specific probiotic combination. It offers a theoretical rationale for developing targeted therapies to treat periodontitis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.